Biofrontera (BFRI) Cash from Operations (2021 - 2025)
Historic Cash from Operations for Biofrontera (BFRI) over the last 5 years, with Q3 2025 value amounting to -$3.8 million.
- Biofrontera's Cash from Operations fell 20278.88% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.0 million, marking a year-over-year increase of 3396.07%. This contributed to the annual value of -$10.3 million for FY2024, which is 5863.45% up from last year.
- Biofrontera's Cash from Operations amounted to -$3.8 million in Q3 2025, which was down 20278.88% from -$3.1 million recorded in Q2 2025.
- Biofrontera's 5-year Cash from Operations high stood at $112000.0 for Q2 2022, and its period low was -$21.0 million during Q4 2021.
- Over the past 5 years, Biofrontera's median Cash from Operations value was -$3.4 million (recorded in 2021), while the average stood at -$4.7 million.
- Its Cash from Operations has fluctuated over the past 5 years, first soared by 11051.64% in 2022, then crashed by 931875.0% in 2023.
- Over the past 5 years, Biofrontera's Cash from Operations (Quarter) stood at -$21.0 million in 2021, then skyrocketed by 60.59% to -$8.3 million in 2022, then decreased by 7.24% to -$8.9 million in 2023, then skyrocketed by 88.73% to -$1.0 million in 2024, then tumbled by 280.0% to -$3.8 million in 2025.
- Its Cash from Operations was -$3.8 million in Q3 2025, compared to -$3.1 million in Q2 2025 and -$4.1 million in Q1 2025.